APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pacemakers and Cardiac Resynchronization Therapy Devices

Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.

Selected research

Industry Research

Pacemakers and Cardiac Resynchronization Therapy Devices Industry Research Report 2026

19 December 2025126 pages

Choose your research edition.

Industry ResearchPacemakers and Cardiac Resynchronization Therapy Devices Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Pacemakers and Cardiac Resynchronization Therapy Devices Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Pacemakers and Cardiac Resynchronization Therapy Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pacemakers and Cardiac Resynchronization Therapy Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.

North America is the largest Pacemakers and Cardiac Resynchronization Therapy Devices market with about 49% market share. Europe is follower, accounting for about 26% market share.

Read the full market overview

The key players are Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 89% market share.

Report Scope

This report quantifies the global Pacemakers and Cardiac Resynchronization Therapy Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pacemakers and Cardiac Resynchronization Therapy Devices Market by Company

Medtronic

St. Jude Medical (Abbott)

Boston Scientific

Biotronik

MicroPort

Medico

Lepu (Qinming Medical)

IMZ

Cardioelectronica

Pacetronix

Pacemakers and Cardiac Resynchronization Therapy Devices Segment by Type

Pacemaker

ICD

CRT

Pacemakers and Cardiac Resynchronization Therapy Devices Segment by Application

Bradycardia

Tachycardia

Heart Failure

Others

Pacemakers and Cardiac Resynchronization Therapy Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pacemakers and Cardiac Resynchronization Therapy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pacemakers and Cardiac Resynchronization Therapy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pacemakers and Cardiac Resynchronization Therapy Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pacemakers and Cardiac Resynchronization Therapy Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pacemakers and Cardiac Resynchronization Therapy Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pacemakers and Cardiac Resynchronization Therapy Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pacemakers and Cardiac Resynchronization Therapy Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue of Manufacturers (2021-2026) Table 9. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pacemakers and Cardiac Resynchronization Therapy Devices Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Pacemakers and Cardiac Resynchronization Therapy Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Product Type & Application Table 14. Global Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pacemakers and Cardiac Resynchronization Therapy Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medtronic Company Information Table 19. Medtronic Business Overview Table 20. Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 22. Medtronic Recent Developments Table 23. St. Jude Medical (Abbott) Company Information Table 24. St. Jude Medical (Abbott) Business Overview Table 25. St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 27. St. Jude Medical (Abbott) Recent Developments Table 28. Boston Scientific Company Information Table 29. Boston Scientific Business Overview Table 30. Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 32. Boston Scientific Recent Developments Table 33. Biotronik Company Information Table 34. Biotronik Business Overview Table 35. Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 37. Biotronik Recent Developments Table 38. MicroPort Company Information Table 39. MicroPort Business Overview Table 40. MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 42. MicroPort Recent Developments Table 43. Medico Company Information Table 44. Medico Business Overview Table 45. Medico Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Medico Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 47. Medico Recent Developments Table 48. Lepu (Qinming Medical) Company Information Table 49. Lepu (Qinming Medical) Business Overview Table 50. Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 52. Lepu (Qinming Medical) Recent Developments Table 53. IMZ Company Information Table 54. IMZ Business Overview Table 55. IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 57. IMZ Recent Developments Table 58. Cardioelectronica Company Information Table 59. Cardioelectronica Business Overview Table 60. Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 62. Cardioelectronica Recent Developments Table 63. Pacetronix Company Information Table 64. Pacetronix Business Overview Table 65. Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio Table 67. Pacetronix Recent Developments Table 68. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region (2021-2026) & (K Units) Table 70. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Region (2021-2026) Table 71. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region (2027-2032) & (K Units) Table 72. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Region (2027-2032) Table 73. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Region (2021-2026) Table 75. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Region (2027-2032) Table 77. North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2026) & (K Units) Table 79. North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2027-2032) & (K Units) Table 80. North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2026) & (K Units) Table 84. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2027-2032) & (K Units) Table 85. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2026) & (K Units) Table 94. South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2027-2032) & (K Units) Table 95. South America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2021-2026) & (K Units) Table 103. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2027-2032) & (K Units) Table 104. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2021-2026) Table 105. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2027-2032) Table 106. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2021-2026) Table 109. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2027-2032) Table 110. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Type (2021-2026) & (USD/Unit) Table 111. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Type (2027-2032) & (USD/Unit) Table 112. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2021-2026) & (K Units) Table 113. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2027-2032) & (K Units) Table 114. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2021-2026) Table 115. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2027-2032) Table 116. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2021-2026) Table 119. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2027-2032) Table 120. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Application (2021-2026) & (USD/Unit) Table 121. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Application (2027-2032) & (USD/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Pacemakers and Cardiac Resynchronization Therapy Devices Distributors List Table 125. Pacemakers and Cardiac Resynchronization Therapy Devices Customers List Table 126. Pacemakers and Cardiac Resynchronization Therapy Devices Industry Trends Table 127. Pacemakers and Cardiac Resynchronization Therapy Devices Industry Drivers Table 128. Pacemakers and Cardiac Resynchronization Therapy Devices Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pacemakers and Cardiac Resynchronization Therapy Devices Product Image Figure 5. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales (2021-2032) & (K Units) Figure 8. Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price (USD/Unit) & (2021-2032) Figure 9. Pacemaker Product Image Figure 10. ICD Product Image Figure 11. CRT Product Image Figure 12. Bradycardia Product Image Figure 13. Tachycardia Product Image Figure 14. Heart Failure Product Image Figure 15. Others Product Image Figure 16. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Pacemakers and Cardiac Resynchronization Therapy Devices Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region in 2025 Figure 22. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region in 2025 Figure 23. North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country in 2025 Figure 24. North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2021-2032) Figure 25. North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2021-2032) Figure 26. United States Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country in 2025 Figure 30. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2021-2032) Figure 31. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2021-2032) Figure 32. Germany Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country in 2025 Figure 43. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2021-2032) Figure 45. China Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country in 2025 Figure 54. South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2021-2032) Figure 55. South America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2021-2032) Figure 56. Brazil Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country in 2025 Figure 61. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2021-2032) Figure 63. Egypt Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2021-2032) Figure 69. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2021-2032) Figure 70. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price (USD/Unit) by Type (2021-2032) Figure 71. Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2021-2032) Figure 72. Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2021-2032) Figure 73. Global Pacemakers and Cardiac Resynchronization Therapy Devices Price (USD/Unit) by Application (2021-2032) Figure 74. Pacemakers and Cardiac Resynchronization Therapy Devices Value Chain Figure 75. Pacemakers and Cardiac Resynchronization Therapy Devices Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Pacemakers and Cardiac Resynchronization Therapy Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Pacemaker
  • ICD
  • CRT
Applications
  • Bradycardia
  • Tachycardia
  • Heart Failure
  • Others
Companies covered
  • Medtronic
  • St. Jude Medical (Abbott)
  • Boston Scientific
  • Biotronik
  • MicroPort
  • Medico
  • Lepu (Qinming Medical)
  • IMZ
  • Cardioelectronica
  • Pacetronix

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size (2021-2032)
  4. 2.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales (2021-2032)
  5. 2.2.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Average Price (2021-2032)
  6. 2.3 Pacemakers and Cardiac Resynchronization Therapy Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pacemaker
  9. 2.3.3 ICD
  10. 2.3.4 CRT
  11. 2.4 Pacemakers and Cardiac Resynchronization Therapy Devices by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Bradycardia
  14. 2.4.3 Tachycardia
  15. 2.4.4 Heart Failure
  16. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pacemakers and Cardiac Resynchronization Therapy Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, Established Date
  9. 3.9 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medtronic
  2. 4.1.1 Medtronic Company Information
  3. 4.1.2 Medtronic Business Overview
  4. 4.1.3 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  6. 4.1.5 Medtronic Recent Developments
  7. 4.2 St. Jude Medical (Abbott)
  8. 4.2.1 St. Jude Medical (Abbott) Company Information
  9. 4.2.2 St. Jude Medical (Abbott) Business Overview
  10. 4.2.3 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  12. 4.2.5 St. Jude Medical (Abbott) Recent Developments
  13. 4.3 Boston Scientific
  14. 4.3.1 Boston Scientific Company Information
  15. 4.3.2 Boston Scientific Business Overview
  16. 4.3.3 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  18. 4.3.5 Boston Scientific Recent Developments
  19. 4.4 Biotronik
  20. 4.4.1 Biotronik Company Information
  21. 4.4.2 Biotronik Business Overview
  22. 4.4.3 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  24. 4.4.5 Biotronik Recent Developments
  25. 4.5 MicroPort
  26. 4.5.1 MicroPort Company Information
  27. 4.5.2 MicroPort Business Overview
  28. 4.5.3 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  30. 4.5.5 MicroPort Recent Developments
  31. 4.6 Medico
  32. 4.6.1 Medico Company Information
  33. 4.6.2 Medico Business Overview
  34. 4.6.3 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  36. 4.6.5 Medico Recent Developments
  37. 4.7 Lepu (Qinming Medical)
  38. 4.7.1 Lepu (Qinming Medical) Company Information
  39. 4.7.2 Lepu (Qinming Medical) Business Overview
  40. 4.7.3 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  42. 4.7.5 Lepu (Qinming Medical) Recent Developments
  43. 4.8 IMZ
  44. 4.8.1 IMZ Company Information
  45. 4.8.2 IMZ Business Overview
  46. 4.8.3 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  48. 4.8.5 IMZ Recent Developments
  49. 4.9 Cardioelectronica
  50. 4.9.1 Cardioelectronica Company Information
  51. 4.9.2 Cardioelectronica Business Overview
  52. 4.9.3 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  54. 4.9.5 Cardioelectronica Recent Developments
  55. 4.10 Pacetronix
  56. 4.10.1 Pacetronix Company Information
  57. 4.10.2 Pacetronix Business Overview
  58. 4.10.3 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Product Portfolio
  60. 4.10.5 Pacetronix Recent Developments
5 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Scenario by Region
  1. 5.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region: 2027-2032
  5. 5.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region: 2027-2032
  8. 5.4 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Facts & Figures by Country
  9. 5.4.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pacemakers and Cardiac Resynchronization Therapy Devices Market Facts & Figures by Country
  41. 5.7.1 South America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pacemakers and Cardiac Resynchronization Therapy Devices Value Chain Analysis
  2. 8.1.1 Pacemakers and Cardiac Resynchronization Therapy Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pacemakers and Cardiac Resynchronization Therapy Devices Production Mode & Process
  5. 8.2 Pacemakers and Cardiac Resynchronization Therapy Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pacemakers and Cardiac Resynchronization Therapy Devices Distributors
  8. 8.2.3 Pacemakers and Cardiac Resynchronization Therapy Devices Customers
9 Global Pacemakers and Cardiac Resynchronization Therapy Devices Analyzing Market Dynamics
  1. 9.1 Pacemakers and Cardiac Resynchronization Therapy Devices Industry Trends
  2. 9.2 Pacemakers and Cardiac Resynchronization Therapy Devices Industry Drivers
  3. 9.3 Pacemakers and Cardiac Resynchronization Therapy Devices Industry Opportunities and Challenges
  4. 9.4 Pacemakers and Cardiac Resynchronization Therapy Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst